Compare OBT & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBT | CADL |
|---|---|---|
| Founded | 1892 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.1M | 339.8M |
| IPO Year | N/A | 2021 |
| Metric | OBT | CADL |
|---|---|---|
| Price | $26.87 | $4.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $29.00 | $19.43 |
| AVG Volume (30 Days) | 19.5K | ★ 651.6K |
| Earning Date | 10-29-2025 | 11-13-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | ★ 18.38 | N/A |
| EPS | ★ 3.03 | N/A |
| Revenue | ★ $115,418,000.00 | N/A |
| Revenue This Year | $19.86 | N/A |
| Revenue Next Year | $7.20 | N/A |
| P/E Ratio | $8.94 | ★ N/A |
| Revenue Growth | ★ 17.75 | N/A |
| 52 Week Low | $20.97 | $4.25 |
| 52 Week High | $30.81 | $14.60 |
| Indicator | OBT | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 59.65 | 37.39 |
| Support Level | $25.01 | $4.35 |
| Resistance Level | $27.72 | $4.87 |
| Average True Range (ATR) | 0.72 | 0.27 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 58.03 | 7.84 |
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.